National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Drug Information
    Posted: 03/02/2007    Updated: 04/30/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Related pages
Drug Information Summaries

Approval Process for New Cancer Treatments

Access to Investigational Drugs: Q & A
Cisplatin

This page contains brief information about cisplatin and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):Platinol-AQ
Platinol
FDA Approved:Yes

Cisplatin is approved by the Food and Drug Administration (FDA) to be used by itself to treat the following conditions:

Cisplatin is approved to be used together with other drugs to treat the following conditions:

In addition to the uses that have been approved by the FDA, cisplatin is sometimes used alone or with other drugs to treat other types of cancer. Cisplatin continues to be studied in the treatment of many types of cancer.

Information from the NCI

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Cisplatin No Better than Standard Therapy for Anal Canal Cancer (04/30/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Stomach Cancer Drug, S-1, Given With Cisplatin, Shows Promise in Japanese Trial (03/12/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Chemotherapy Before Surgery May Increase Survival in Stomach Cancer (07/09/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Meta-Analysis Suggests Cisplatin Superior to Carboplatin for Advanced Non-Small Cell Lung Cancer (06/19/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Long-Term Data Support Cisplatin-Based Chemoradiation for Cervical Cancer (05/29/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Surgery Does Not Improve Survival for Advanced Non-Small Cell Lung Cancer Patients (04/17/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Patients With Esophageal Cancer May Be Able to Avoid Surgery (04/16/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Impact of Intraperitoneal Chemotherapy on Quality of Life During Ovarian Cancer Treatment (02/14/2007) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: ERCC1 Expression in Lung Cancer May Predict Survival Benefit from Cisplatin (09/20/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Chemotherapy Superior to Radiation for Uterine Sarcoma (06/27/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Cisplatin Improves Survival in Non-Small Cell Lung Cancer (06/04/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Elderly Benefit From Chemotherapy for Early NSCLC (06/03/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Chemotherapy During Radiation Best for Nasopharyngeal Cancer (02/15/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Cisplatin Plus Topotecan Gives Advanced Cervical Cancer Patients More Time (08/17/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Chemotherapy Better Than Radiation for Advanced Endometrial Cancer (12/21/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Announcement for Preferred Method of Treatment for Advanced Ovarian Cancer - Questions and Answers (01/04/2006) - Information about the use of this drug to treat cancer.

Information from the NLM

MedlinePlus Information on Cisplatin - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials

Clinical Trials for Cisplatin - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov